Patents by Inventor Christine VOIGT

Christine VOIGT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for Treating Antibody-Mediated Rejection
    Publication number: 20240000908
    Abstract: The invention relates to methods of treating antibody-mediated rejection in a subject comprising administering C1-INH to the subject according to a schedule with the following steps: (a) intravenously administering one or more iv-doses of C1-INH, (b) subcutaneously administering at least 10 sc-doses of C1-INH over several weeks, wherein each week at least one sc-dose is administered. The invention further relates to a method of treating antibody-mediated rejection in a transplant recipient comprising subcutaneously administering C1-INH over at least 10 weeks, wherein each week at least one sc-dose is administered.
    Type: Application
    Filed: November 18, 2021
    Publication date: January 4, 2024
    Applicant: CSL Behring GmbH
    Inventors: John Roberts, Marc Uknis, Christine Voigt
  • Methods for reducing risk of onset of acute graft versus host disease after hematopoietic cell transplantation
    Patent number: 11857610
    Abstract: This disclosure relates to methods for preventing or reducing the risk of development of graft versus host disease (GVHD) in patients receiving hematopoietic cell transplantation (HCT) by particular methods of administering alpha-1 antitrypsin (A1AT or AAT) to patients both prior to and following and HCT procedure. The disclosure also relates to specific methods of treating acute GVHD (aGVHD) after HCT with A1AT.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: January 2, 2024
    Assignee: CSL Behring LLC
    Inventors: Marc Uknis, Christine Voigt, Gautam Baheti, John Roberts
  • METHODS FOR REDUCING RISK OF ONSET OF ACUTE GRAFT VERSUS HOST DISEASE AFTER HEMATOPOEITIC CELL TRANSPLANTATION
    Publication number: 20210008182
    Abstract: This disclosure relates to methods for preventing or reducing the risk of development of graft versus host disease (GVHD) in patients receiving hematopoietic cell transplantation (HCT) by particular methods of administering alpha-1 antitrypsin (A1AT or AAT) to patients both prior to and following and HCT procedure. The disclosure also relates to specific methods of treating acute GVHD (aGVHD) after HCT with A1AT.
    Type: Application
    Filed: November 30, 2018
    Publication date: January 14, 2021
    Applicant: CSL Behring LLC
    Inventors: Marc UKNIS, Christine VOIGT, Gautam BAHETI, John ROBERTS
  • 21-DAY DOSING REGIMEN FOR FUSION PROTEINS COMPRISING FACTOR IX AND HUMAN ALBUMIN FOR PROPHYLACTIC TREATMENT OF HEMOPHILIA AND METHODS THEREOF
    Publication number: 20200115436
    Abstract: The present invention relates to prophylactic dosing regimens with about 90-110 IU/kg long-acting factor IX (human FIX-human albumin) in dosing intervals of about three weeks (e.g., 21 days).
    Type: Application
    Filed: June 29, 2018
    Publication date: April 16, 2020
    Inventors: Yanyan LI, Debra BENSEN-KENNEDY, Iris JACOBS, Christine VOIGT
  • SUBCUTANEOUS ADMINISTRATION OF LONG-ACTING FACTOR IX IN HUMANS
    Publication number: 20200093901
    Abstract: The present invention relates to clinically relevant dosing regimens of prophylactic subcutaneously administered long-acting factor IX (i.e., human FIX fused to human albumin) in human patients.
    Type: Application
    Filed: July 7, 2017
    Publication date: March 26, 2020
    Inventors: Christine VOIGT, Shilpa PULI, John ROBERTS, Marc NOLTE
  • FUSION PROTEINS COMPRISING FACTOR IX FOR PROPHYLACTIC TREATMENT OF HEMOPHILIA AND METHODS THEREOF
    Publication number: 20160346366
    Abstract: The present invention relates to prophylactic dosing regimens with long-acting factor IX (FIX) in dosing intervals of 1 week or longer, including (but not limited to) 10 days or longer, such as two weeks, three weeks or even monthly.
    Type: Application
    Filed: December 1, 2014
    Publication date: December 1, 2016
    Inventors: Iris JACOBS, Debra BENSEN-KENNEDY, Christine VOIGT